Background: Osteoarthritis (OA) is a major clinical and public health problem, with no current medications approved as having disease modifying effects. HMG-CoA reductase inhibitors, or "statins", a drug class widely used to prevent cardiovascular events, could potentially affect OA progression via a number of mechanisms including their effects on lipid metabolism and inflammation. The aim of this multicentre, randomised, double-blind, placebo-controlled trial is to determine whether atorvastatin reduces the progression of knee structural changes and symptoms over 2 years in patients with symptomatic knee OA.Methods/design350 patients with symptomatic knee OA will be recruited through the OA Clinical Trial Network (in Melbourne, Hobart and Adelaide). They will be randomly allocated to the two arms of the study, receiving either 40 mg of atorvastatin or identical placebo once daily for 2 years. Magnetic resonance imaging of the knee will be performed at baseline and 2 years later. Knee structure, symptoms and function will be assessed using validated methods. The primary outcome is annual percentage change in knee cartilage volume. Secondary outcomes include progression of cartilage defects, bone marrow lesions, knee pain and function. The primary analysis will be by intention to treat, but per protocol analyses will also be performed.DiscussionThe study will provide high-quality evidence to address whether atorvastatin has a novel disease modifying effect in OA by delaying the structural and symptomatic progression of knee OA. Thus, the trial has major public health and clinical importance, as if found to be beneficial, atorvastatin could produce substantial cost savings by delaying and possibly reducing the need for joint replacement surgery, and provide marked improvements in quality of life for people with OA.Trial registrationAustralian New Zealand Clinical Trials Registry: ACTRN12613000190707, registered on 18 February 2013.
from #Medicine via ola Kala on Inoreader http://ift.tt/1JuUo5j
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
2015
(2119)
-
▼
Δεκεμβρίου
(940)
-
▼
Δεκ 23
(50)
- Braın abscess due to Streptococcus intermedius sec...
- Terlipressin and albumin for type 1 hepatorenal sy...
- CT-guided biopsy of lung lesions using two needles...
- Evaluation of a systematic approach to weaning of ...
- The impact of system matrix dimension on small FOV...
- Effect of deformable registration uncertainty on l...
- Osmotic potential calculations of inorganic and or...
- Flattening filter free beams from TrueBeam and Ver...
- Discontinuous finite element space-angle treatment...
- Constructing the ecstasy of MDMA from its componen...
- Strategy To Fabricate Naked-Eye Readout Ultrasensi...
- Enhanced Mass Defect Filtering To Simplify and Cla...
- Cross-sector surveys assessing perceptions of key ...
- Diagnosis of early-stage esophageal cancer by Rama...
- Micro movements of the upper limb in fibromyalgia:...
- The curative efficacy of arthroscopic therapy in t...
- Does statin use have a disease modifying effect in...
- Plasmonic nanostructures for surface enhanced spec...
- Study of Oral Ceritinib in Patients With ALK-Activ...
- The neurophysiology of failed visual perceptions: ...
- Life, Vol. 6, Pages 1: Landmarks in the Evolution ...
- Healthcare, Vol. 4, Pages 1: Shortening a Patient ...
- Molbank, Vol. 2016, Article M882: 1,3-Bis(5′-methy...
- Marine Drugs, Vol. 14, Pages 2: In Vitro and in Vi...
- Humanities, Vol. 5, Pages 1: Double Blind Peer-Rev...
- JDB, Vol. 4, Pages 1: Beyond the Mammalian Heart: ...
- Laws, Vol. 5, Pages 1: Services in the Field of La...
- JoF, Vol. 2, Pages 1: Colliding Epidemics and the ...
- Diagnostics, Vol. 6, Pages 2: Ultrasonography of t...
- Insects, Vol. 7, Pages 1: Antagonistic Interaction...
- Making the invisible visible: Improved electrospra...
- Preclinical mouse models for assessing axial compr...
- Role of Irisin on the bone–muscle functional unit
- Skeletal stem cells for bone development, homeosta...
- Sulfiredoxin inhibitor induces preferential death ...
- Down-regulation of the mitochondrial matrix peptid...
- Neuroprotective potential of molecular hydrogen ag...
- ZYZ451 Protects Cardiomyocytes from Hypoxia-induce...
- Caffeic acid prevents acetaminophen-induced liver ...
- Fructose-derived advanced glycation end-products d...
- Polymers, Vol. 8, Pages 1: Comparative Indoor and ...
- Biology, Vol. 5, Pages 1: Cell Adhesion Molecules ...
- Micromachines, Vol. 7, Pages 1: Miniature Microwav...
- Chemosensors, Vol. 4, Pages 1: Building Selectivit...
- Bioengineering, Vol. 3, Pages 1: Sustained Release...
- Cancers, Vol. 8, Pages 2: Diverse Mechanisms of Sp...
- Catalysts, Vol. 6, Pages 1: Catalytic Conversion o...
- Behavioral Sciences, Vol. 6, Pages 1: Adolescent P...
- Minerals, Vol. 6, Pages 1: New Insights in the Ont...
- Algorithms, Vol. 9, Pages 2: Offset-Assisted Facto...
-
▼
Δεκ 23
(50)
-
▼
Δεκεμβρίου
(940)
Αναζήτηση αυτού του ιστολογίου
Τετάρτη 23 Δεκεμβρίου 2015
Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? Study protocol for a randomised controlled trial
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.